Cardiac fibrosis is a common pathological consequence of most myocardial diseases. It is
associated with the excessive accumulation of extracellular matrix proteins as well as …

Chronic kidney disease is associated with an increased risk for the development and
progression of cardiovascular disorders including hypertension, dyslipidemia, and coronary …

Chronic kidney disease is a global health problem affecting 10% to 12% of the population.
Uremic cardiomyopathy is often characterized by left ventricular hypertrophy, fibrosis, and …

Radiation-induced heart disease (RIHD) is a potential late side-effect of thoracic
radiotherapy resulting in left ventricular hypertrophy (LVH) and fibrosis due to a complex …

Uremic cardiomyopathy is characterized by diastolic dysfunction, left ventricular hypertrophy
(LVH), and fibrosis. Dysregulation of the kisspeptin receptor (KISS1R)-mediated pathways …

The cardiorenal syndrome (CRS) is described as a multi‐organ disease encompassing
bidirectionally heart and kidney. In CRS type 4, chronic kidney disease (CKD) leads to …

Abstract Background Metabolic syndrome (MetS) refers to a cluster of co-existing cardio-
metabolic risk factors, including visceral obesity, dyslipidemia, hyperglycemia with insulin …

Chronic kidney disease (CKD) is associated with anxiety; however, its exact mechanism is
not well understood. Therefore, the aim of the present study was to assess the effect of …

Despite the effectiveness of doxorubicin (DOXO) as a chemotherapeutic agent, dose-
dependent development of chronic cardiotoxicity limits its application. The angiotensin-II …

Background Mirabegron (MIRG) is a type of β3 adrenoceptor agonist that is considered an
alternative therapy for the treatment of overactive bladder (OAB) symptoms. Cilostazol (CITZ) …